The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of pacritinib, an interleukin 1 receptor associated kinase 1 (IRAK1) inhibitor, in patients (pts) with solid tumors harboring the 1q21.3 copy number amplification (CNA).
 
Joline Si Jing Lim
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; DKSH; Gilead Sciences; MSD; Novartis; Pfizer
Research Funding - CTI BioPharma Corp (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Pfizer
 
Mei Yee Aau
No Relationships to Disclose
 
Joe Yeong
No Relationships to Disclose
 
Boon Cher Goh
Stock and Other Ownership Interests - Avantor; Gilead Sciences
Honoraria - Merck Serono; MSD; Novartis
Consulting or Advisory Role - Merck Serono; MSD; Novartis
Research Funding - Adagene; Bayer; Bristol-Myers Squibb; MSD; Taiho Oncology
 
Wei Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Bayer; Eisai; Lilly; MSD; Sanofi/Aventis; Taiho Oncology
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; J INTS BIO; J INTS BIO; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; J INTS BIO; Janssen; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Taiho Pharmaceutical; Takeda; Thermo Fisher Scientific; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Andrea Wong
Consulting or Advisory Role - AstraZeneca; Eisai; Novartis; Pfizer
Research Funding - Otsuka
 
David Shao Peng Tan
Stock and Other Ownership Interests - Asian Microbiome Library
Honoraria - AstraZeneca; Bayer; Eisai; Foundation Medicine; Merck; MSD; Roche; Turbine
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Merck; MSD; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics; Roche
Travel, Accommodations, Expenses - AZD; Bayer; Merck; Novartis; Roche
 
Cheng Ean Chee
Consulting or Advisory Role - Guardant Health
Speakers' Bureau - AstraZeneca; Roche
 
Raghav Sundar
Stock and Other Ownership Interests - Teladoc
Honoraria - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; DKSH; Ipsen; MSD; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Daiichi Sankyo/Astra Zeneca; DKSH; Eisai; GlaxoSmithKline; Pierre Fabre; Sanofi; Tavotek BioTherapeutics
Research Funding - CytoMed (Inst); MSD (Inst); Natera (Inst); Paxman (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patent (pending): Method Of Predicting For Benefit From Immune Checkpoint Inhibition Therapy; Inventor on patent (pending): Portable Limb Compression System; Inventor on patent (pending): Wearable Limb Wraps for Temperature-Controlled Therapy
Travel, Accommodations, Expenses - AstraZeneca; CytoMed Therapeutics; DKSH; Ipsen; Taiho Pharmaceutical
 
Anand Devaprasath Jeyasekharan
Honoraria - AstraZeneca; Janssen; MSD
Consulting or Advisory Role - Antengene; AstraZeneca; DKSH/Beigene; Gilead Sciences; Janssen; MSD; Roche; Turbine Ltd
Research Funding - AstraZeneca; Janssen
Travel, Accommodations, Expenses - Perkin Elmer
 
Calista Wong
No Relationships to Disclose
 
Polly Leilei Chen
No Relationships to Disclose
 
Hai Yan Liu
No Relationships to Disclose
 
Qiang Yu
No Relationships to Disclose
 
Wai Leong Tam
No Relationships to Disclose
 
Soo-Chin Lee
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - Adagene; ASLAN Pharmaceuticals; Bayer; Eisai; Karyopharm Therapeutics; Pfizer; Taiho Pharmaceutical
Expert Testimony - Novartis
Travel, Accommodations, Expenses - ACT Genomics; AstraZeneca/MedImmune; Novartis; Pfizer; Roche